As Senior Strategic Advisor to Medicines360, Jamie develops effective strategies that actualize the main mission of the organization – expanding access to health innovations for all women.

Jamie is a passionate mission-driven health science strategist and advisor. She works across sectors, ranging from government to philanthropy, industry to academia, and advocacy, in pursuit of creating cross-sector and multinational partnerships that improve health.

Previously, she acted as the Health Science Strategy and Relations Lead and a Health Science Policy Analyst at the National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH). In this position, she provided strategic guidance to leadership concerning policy and programmatic challenges in science, health, and the biomedical workforce that were of significance to the agency. In addition, she led a wide range of staff functions involving strategy, visioning, and process planning, as well as creating sustained external and internal partnerships through strategic engagement, including the Innovation Equity Forum (IEF). Jamie began her career at NIH as a Presidential Management Fellow (PMF) – STEM track, serving as the Special Assistant to the Director of ORWH. Prior to working for NIH, she held several positions including Laboratory Analyst at the Blue Grass Chemical Agent-Destruction Pilot Plant (BGCAPP) and Research Chemist at the Center for Disease Control and Prevention (CDC).

Jamie has published several peer reviewed articles and frequently speaks at both domestic and international forums. She has expertise in multiple disciplines, including global women’s health innovation, sex, gender & intersectionality, precision medicine and personalized care, analytical chemistry, behavioral neuroendocrinology, bioethics, government affairs, and policy.

Recently, she was awarded the American Medical Women’s Association (AMWA) Presidential Recognition Award, First in Femtech Award, her third NIH Director’s Award, and named in the 200 Trailblazing Leaders in Women’s Health and FemTech for her work on the Women’s Health Innovation Opportunity Map. She is proud to be the Founder and CEO of innovative Health Science (iHS) Strategies, LLC.

Jamie attained her graduate degree in neuroscience at Tulane University and is a proud alumna of Spelman College and the Gates Millennium Scholars Program. Currently, she is on the Advisory Board of the Women’s Health Innovation Series, member of the MedTech Color Community Collaborative and serves on the XPrize Global Visioneering Brain Trust – Health Domain and on the Board of Directors for the impact of Gender/Sex on Innovation and Novel Technologies (iGIANT) organization.